Myopia

Latest News

Implication of secondhand smoke in greater risk of development of myopia in Chinese children - ©pongmoji—stock.adobe.com
Implication of secondhand smoke in greater risk of development of myopia in Chinese children

July 14th 2025

A study reveals that secondhand smoke significantly increases the risk of myopia in Chinese children, highlighting the need for smoke-free environments.

Child undergoing eye exam Image credit: AdobeStock/AlexisS/peopleimages.com
CooperVision’s Generation Sight initiative expands its reach for myopia management treatment

June 25th 2025

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces - Image credit: ©artjazz—stock.adobe.com
European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

June 5th 2025

Atropine vs spectacles- Which move will be more powerful in the game of myopia management - Image credit: ©Vlad - stock.adobe.com
Atropine vs spectacles: Which move will be more powerful in the game of myopia management?

June 5th 2025

iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia ©OHishi_Foto—stock.adobe.com
iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia

June 4th 2025

Video Interviews
Podcasts
You and Eye by Optometry Times with host Miriam Korik, OD
Latest CME Events & Activities

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)

View More

Retina Specialists: Join us in Long Beach

July 31, 2025 - August 2, 2025

Register Now!

SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application

View More

3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between

September 6, 2025

Register Now!

Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D

View More

EyeCon 2025

September 26-27, 2025

Register Now!

Optometrists: Earn COPE CE Credits in Portland or Virtually

October 16-17, 2025

Register Now!

Join us at The Ophthalmology Meeting in Orlando this October

October 18, 2025

Register Now!

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

View More

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

Expert Perspectives on Technological Advances in Cataract Surgery

View More

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

View More

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

View More

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

View More

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

View More

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

View More

(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

View More

EnVision Summit

February 13-16, 2026

Register Now!

(CME Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

View More

Practical Approaches to Modern Dry Eye Treatment and Management

View More

(COPE Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches

View More

More News

© 2025 MJH Life Sciences

All rights reserved.